Acute Coronary SyndromeSyndromeAngina, UnstableCoronary AngiographyMyocardial InfarctionCoronary VesselsPrognosisCoronary Artery DiseasePlatelet Aggregation InhibitorsAngioplasty, Balloon, CoronaryCoronary DiseaseAcute DiseaseTiclopidineChest PainCoronary ThrombosisCoronary CirculationBiological MarkersTreatment OutcomeRisk FactorsElectrocardiographyHemorrhagePlatelet Glycoprotein GPIIb-IIIa ComplexCoronary StenosisTroponin TProspective StudiesCoronary Artery BypassAngina PectorisPercutaneous Coronary InterventionMyocardial RevascularizationRisk AssessmentTroponin IPredictive Value of TestsTime FactorsMyocardial IschemiaFollow-Up StudiesPurinergic P2Y Receptor AntagonistsAspirinPlaque, AtheroscleroticEnoxaparinCreatine Kinase, MB FormCoronary Care UnitsAnticoagulantsUltrasonography, InterventionalC-Reactive ProteinCoronary VasospasmHeptanoic AcidsTroponinRetrospective StudiesFibrinolytic AgentsStentsHospitalizationAngina, StableHydroxymethylglutaryl-CoA Reductase InhibitorsRecurrenceThiophenesCardiovascular AgentsRupture, SpontaneousKaplan-Meier EstimateRegistriesHirudinsMultivariate AnalysisAcetanilidesHospital MortalityCoronary AneurysmPyrrolesHeparinCoronary RestenosisThrombosisSeverity of Illness IndexRandomized Controlled Trials as TopicProportional Hazards ModelsChi-Square DistributionSurvival AnalysisAngioscopyCoronary OcclusionTriageDrug Therapy, CombinationHirudin TherapyCardiac CatheterizationDouble-Blind MethodCohort StudiesCreatine KinaseThrombolytic TherapySensitivity and SpecificityPravastatinIncidenceNatriuretic Peptide, BrainPlatelet ActivationROC CurveCase-Control StudiesMetabolic Syndrome XLogistic ModelsAlbaniaSecondary PreventionVascular CalcificationAge FactorsImmunoglobulin Fab FragmentsEmergency Medical ServicesNo-Reflow PhenomenonStroke